Table 3.
Meta-analysis of decreased Muc5AC expression and clinicopathological characteristics of gastric cancer
| Clinicopathological characteristic | No. of studies | No. of patients | Pooled OR (95%CI) |
Heterogeneity |
|
| I2 | P-value | ||||
| TNM stage | 4 | 801 | 1.15 (0.56-2.34), Random | 78% | 0.003 |
| Tumor size | 3 | 257 | 1.38 (0.84-2.28), Fixed | 0% | 0.83 |
| Venous invasion | 3 | 394 | 1.26 (0.82-1.94), Fixed | 35% | 0.21 |
| Lymphatic invasion | 3 | 650 | 1.27 (0.89-1.80), Fixed | 25% | 0.26 |